Home Banner

MOH Guidelines on the Human Biomedical Research Act - please click here.

 

Latest News


important notice




important notice










important notice






important notice














important notice







important notice








important notice











NUS-IRB COVID-19 Information

In view of the COVID-19 situation, we have put together an information sheet for researchers. Please view / download the information sheet below.

COVID-19 Information Sheet





NUS INTEGRATED RESEARCH INFORMATION MANAGEMENT SUITE - INSTITUTIONAL REVIEW BOARD (iRIMS-IRB)

From 1 July 2020, all new applications to NUS-IRB must be submitted through iRIMS-IRB.

iRIMS-IRB is the first module to be implemented and will gradually replace the existing, manual paper-based ethics submissions to the NUS Institutional Review Board (NUS-IRB). The new system includes features such as online submission of various compliance applications, and automatic routing to facilitate review and approval.

PIs and researchers can now submit new IRB applications involving human subjects and/or human biological materials and/or human data online using the system.

Please visit the iRIMS-IRB page for more details.



PROTOCOL AMENDMENT SUBMISSIONS FOR ONGOING RESEARCH IMPACTED BY CIRCUIT BREAKER

In view of the restrictions on research activities which remain in place despite the partial lifting of the circuit breaker, PIs who are conducting face-to-face interviews or self-administered questionnaires as part of the research visit may wish to submit an application for a protocol amendment to the NUS-IRB to conduct remote online interviews instead, e.g., via Skype, Zoom, etc or online surveys eg Qualtrics. Please let the IRB have your application form for protocol amendment and the documents amended by the change. We will process these as soon as possible. Thank you.



LAUNCH OF NUS INTEGRATED RESEARCH INFORMATION MANAGEMENT SUITE - INSTITUTIONAL REVIEW BOARD (iRIMS-IRB)

We are pleased to launch the NUS Integrated Research Information Management Suite-Institutional Review Board (iRIMS-IRB) system on 1 Jun 2020.

iRIMS-IRB is the first module to be implemented and will gradually replace the existing, manual paper-based ethics submissions to the NUS Institutional Review Board (NUS-IRB). The new system includes features such as online submission of various compliance applications, and automatic routing to facilitate review and approval.

PIs and researchers can now submit IRB applications involving human subjects and/or human biological materials and/or human data online using the system.

As we transition to the new system, NUS-IRB will continue to accept softcopy submissions until 30 June 2020. From 1 July 2020, all applications to NUS-IRB must be submitted through iRIMS-IRB.

Please visit the iRIMS-IRB page for more details.


ONLY SOFT COPIES IRB APPLICATIONS WILL BE ACCEPTED WITH IMMEDIATE EFFECT

In view of the new work-from-home measures, the NUS-IRB office will only be accepting soft copies IRB applications. Please do not send hard copies applications to our office.

If you have already sent in your hard copy application, please send the soft copies to irb@nus.edu.sg.



NUS RCIO ANNOUNCEMENT ON CONSENT-TAKING, TISSUE BANKING, AND INCIDENTAL FINDINGS POLICY UPDATES


With the expiry of HBR consent-taking exemptions, activation of Tissue Banking Regulations and related regulatory amendments effective 1 Nov 2019, the Research Compliance and Integrity Office (RCIO) has issued an announcement on appropriate consents, NUS Tissue Bank principal person-in-charge (PIC), and updates to their Incidental Findings policy. Please refer to RCIO's website for more details. Researchers may reach out to rcio@nus.edu.sg for enquiries on the above announcement and updated policy.

Updates on the tissue banking regulations can be accessed from the Singapore Ministry of Health (MOH)'s webpage here.



1. "ETHICS REVIEW OF FACULTY RESEARCH BY DERC" GUIDELINES

With effect from 1 June 2019, some faculty research can be reviewed by the Departmental Ethics Review Committee (DERC). Please refer to the new guidelines on "Ethics review of faculty research by DERC" for more information.


2. NEW FORMS AND GUIDELINES ON SERIOUS ADVERSE EVENTS, NON-COMPLIANCE/ DEVIATION AND (UN)EXPECTED EVENTS 

Three new forms and their guidelines have been uploaded for researchers' use. Please refer to the "Forms" tab.

 

Guidelines and Forms are accessible to NUS researchers only. For non-NUS researchers, please contact irb@nus.edu.sg.